BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20878505)

  • 1. Cytostatic drugs, neuregulin activation of erbB receptors, and angiogenesis.
    Hedhli N; Russell KS
    Curr Hypertens Rep; 2010 Dec; 12(6):411-7. PubMed ID: 20878505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1/ErbB-PI3K/Akt/mTOR pathway.
    Wang J; Zhou J; Wang Y; Yang C; Fu M; Zhang J; Han X; Li Z; Hu K; Ge J
    J Cell Mol Med; 2017 Sep; 21(9):1905-1914. PubMed ID: 28271613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity.
    Sawyer DB; Zuppinger C; Miller TA; Eppenberger HM; Suter TM
    Circulation; 2002 Apr; 105(13):1551-4. PubMed ID: 11927521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
    Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
    J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of neuregulin-1/ErbB signaling: role in vascular signaling and angiogenesis.
    Hedhli N; Kalinowski A; S Russell K
    Curr Pharm Des; 2014; 20(30):4899-905. PubMed ID: 24283954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of neuregulin-1 in cardiovascular disease.
    Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin in heart failure : reverse translation from cancer cardiotoxicity to new heart failure therapy.
    Geisberg CA; Lenihan DJ
    Herz; 2011 Jun; 36(4):306-10. PubMed ID: 21633805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk.
    Lemmens K; Segers VF; Demolder M; De Keulenaer GW
    J Biol Chem; 2006 Jul; 281(28):19469-77. PubMed ID: 16698793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuregulin-1 and its potential role in the control of cardiac function.
    Lemmens K; Doggen K; Keulenaer GW
    Heart Fail Monit; 2008 Feb; 5(4):119-24. PubMed ID: 18273495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes.
    Kuramochi Y; Guo X; Sawyer DB
    J Mol Cell Cardiol; 2006 Aug; 41(2):228-35. PubMed ID: 16769082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.
    Schneider JW; Chang AY; Rocco TP
    Semin Oncol; 2001 Oct; 28(5 Suppl 16):18-26. PubMed ID: 11706392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW; Stonecypher MS; Carroll SL
    Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes.
    Timolati F; Ott D; Pentassuglia L; Giraud MN; Perriard JC; Suter TM; Zuppinger C
    J Mol Cell Cardiol; 2006 Nov; 41(5):845-54. PubMed ID: 17005195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.
    Fedele C; Riccio G; Malara AE; D'Alessio G; De Lorenzo C
    Breast Cancer Res Treat; 2012 Jul; 134(2):595-602. PubMed ID: 22674190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway.
    Liu J; Nethery D; Kern JA
    Exp Lung Res; 2004 Sep; 30(6):465-78. PubMed ID: 15524405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HER2 in angiogenesis.
    Kumar R; Yarmand-Bagheri R
    Semin Oncol; 2001 Oct; 28(5 Suppl 16):27-32. PubMed ID: 11706393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin1 as novel therapy for heart failure.
    Yan X; Morgan JP
    Curr Pharm Des; 2011; 17(18):1808-17. PubMed ID: 21631420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Neuregulin-1beta/ErbB signaling in the heart.
    Pentassuglia L; Sawyer DB
    Exp Cell Res; 2009 Feb; 315(4):627-37. PubMed ID: 18801360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
    Friedländer E; Arndt-Jovin DJ; Nagy P; Jovin TM; Szöllosi J; Vereb G
    Cytometry A; 2005 Oct; 67(2):161-71. PubMed ID: 16163699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.